Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01980537
Other study ID # Stereotaxis and CTO
Secondary ID
Status Completed
Phase N/A
First received October 24, 2013
Last updated November 4, 2013
Start date April 2008

Study information

Verified date November 2013
Source Medical University of Vienna
Contact n/a
Is FDA regulated No
Health authority Austria: AGES (Österreichische Agentur für Gesundheit und Ernährungssicherheit) - Austrian Agency for Health and Food Safety
Study type Interventional

Clinical Trial Summary

Wire-crossing of a chronic total coronary occlusion (CTO) is time-consuming and limited by the amount of contrast agent and time of radiation exposure. Magnetic wire navigation might accelerate wire-crossing by maintaining a coaxial vessel orientation. This study compares magnetic with conventional wire navigation for recanalization of CTOs.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date
Est. primary completion date April 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- symptomatic

- preserved wall motion or viable myocardium

- chronic total occlusion

Exclusion Criteria:

- chronic renal failure

- prior allergic reactions against contrast agent

- hyperthyreosis

- claustrophobia

- pregnancy

- contraindications to aspirin or clopidogrel

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Magnetic wire navigation

Conventional wire navigation


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Medical University of Vienna

Outcome

Type Measure Description Time frame Safety issue
Primary level of contrast medium 8 hours Yes
See also
  Status Clinical Trial Phase
Recruiting NCT04542460 - The Nordic Baltic Chronic Total Occlusion (CTO) Arrhythmia Study N/A